Back to results
US 2017/0362219 A1Published application
Substituted dihydro-1h-pyrrolo[3,2-c]pyridin-4(5h)-ones as ripk3 inhibitors
AssigneeBristol-Myers Squibb Company
InventorsAmy C. HART, William J. PITTS, Harold MASTALERZ, Junqing GUO, Gregory D. BROWN
Life of this patent
Estimating the term…
Abstract
Compounds having Formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK3 modulation. All the variables defined herein.
Claims14
A compound according to Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- --- is an optional bond;
- R1 is selected from —(CRdRd)r-C3-10 carbocyclyl substituted with 1-5 R5, —CRd═CRd—C3-10 carbocyclyl substituted with 1-5 R5, and heterocyclyl comprising carbon atoms and 1 to 3 heteroatoms selected from N, O, S, and substituted with 1-5 R5;
- L is selected from —(CRdRd)r— and —S(O)p—;
- R2 is selected H, C1-2 alkyl substituted with 0-3 Re, carbocyclyl substituted with 1-8 R7, heterocyclyl, comprising carbon atoms and 1 to 4 heteroatoms selected from N, O, S, wherein said heterocyclyl is substituted with 1-8 R7;
- R3 is selected from H, CN, C1-4 alkyl substituted with 0-3 Re, —C(═O)ORb, —C(═O)NRaRa, —C(═O)Rb, —NRaC(═O)Rb, —NRaC(═O)ORb, C3-6carbocycle substituted with 0-3 Re, and heterocycle substituted with 0-3 Re;
- R4 is selected from
- and 5-membered heteroaryl substituted with 1-5 R6;
- A1, A2, and A3 are independently selected from N and CR6;
- provided A1, A2, and A3 are not all nitrogen;
- R5 is selected from H, C1-4 alkyl substituted with 0-3 Re, F, Cl, Br, ═O, CN, NO2, —(CH2)rCN, —(CH2)rORb, (CH2)rS(O)pRc, —(CH2)rC(═O)Rb, —(CH2)rNRaRa, —(CH2)rC(═O)NRaRa, —(CH2)rNRaC (═O)Rb, —(CH2)rNRaC (═O)ORb, —(CH2)rOC(═O)NRaRa, —(CH2)rNRaC(═O)NRaRa, —(CH2)rC(═O)ORb, —(CH2)rS(O)2NRaRa, —(CH2)rNRaS(O)2NRaRa, —(CH2)rNRaS(O)2Rc, (CH2)r-carbocyclyl substituted with 0-3 Re, and —(CH2)r-heterocyclyl substituted with 0-3 Re;
- R6 is selected from H, F, Cl, Br, C1-4 alkyl substituted with 0-3 Re, —(CH2)rCN, —(CH2)rORb, (CH2)rS(O)pRc, —(CH2)rC(═O)Rb, —(CH2)rNRaRa, —(CH2)rC(═O)NRaRa, —(CH2)rC(═O)—C1-4 alkyl substituted with 0-3 Re, —(CH2)rNRaC(═O)Rb, —(CH2)rNRaC(═O)ORb, —(CH2)rOC(═O)NRaRa, —(CH2)rNRaC(═O)NRaRa, —(CH2)rC(═O)ORb, —(CH2)rS(O)2NRaRa, —(CH2)rNRaS(O)2NRaRa, —(CH2)rNRaS(O)2Rc, (CH2)r-carbocyclyl substituted with 0-3 Re, and —(CH2)r-heterocyclyl substituted with 0-3 Re;
- alternatively, two adjacent R6 groups are taken together to form a heterocycle;
- R7, at each occurrence, is independently selected from H, F, Cl, Br, ═O, CN, NO2, —ORb, —S(O)pRe, —C(═O)Rb, —(CRdRd)rNRaRa, —(CRdRd)rC(═O)NRaRa, —NRaC(═O)Rb, —NRaC(═O)ORb, —OC(═O)NRaRa, —NRaC(═O)NRaRa, —(CRdRd)rC(═O)ORb, —S(O)2NRaRa, —NRaS(O)2NRaRa, —NRaS(O)2Rc, C1-6 alkyl substituted with 0-5 Re, —(CRdRd)r—C3-6carbocyclyl substituted with 0-5 Re, and —(CRdRd)r-heterocyclyl substituted with 0-5 Re;
- Ra, at each occurrence, is independently selected from H, CN, C1-6 alkyl substituted with 0-5 Re, C2-6 alkenyl substituted with 0-5 Re, C2-6 alkynyl substituted with 0-5 Re, —(CH2)r—C3-10carbocyclyl substituted with 0-5 Re, and —(CH2)r-heterocyclyl substituted with 0-5 Re;
- or Ra and Ra together with the nitrogen atom to which they are both attached form a heterocyclic ring substituted with 0-5 Re;
- Rb, at each occurrence, is independently selected from H, C1-6 alkyl substituted with 0-5 Re, C2-6 alkenyl substituted with 0-5 Re, C2-6 alkynyl substituted with 0-5 Re, —(CH2)r—C3-10carbocyclyl substituted with 0-5 Re, and —(CH2)r-heterocyclyl substituted with 0-5 Re;
- Rc, at each occurrence, is independently selected from C1-6 alkyl substituted with 0-5 Re, C2-6alkenyl substituted with 0-5 Re, C2-6alkynyl substituted with 0-5 Re, C3-6carbocyclyl, and heterocyclyl;
- Rd, at each occurrence, is independently selected from H and C1-4alkyl substituted with 0-5 Re;
- or Rd and Rd together are ═O;
- Re, at each occurrence, is independently selected from C1-6 alkyl substituted with 0-5 Rf, C2-6 alkenyl, C2-6 alkynyl, aryl, —(CH2)r—C3-6 cycloalkyl, F, Cl, Br, CN, NO2, ═O, CO2H, —C(═O)NRfRf, —(CH2)rORf, SRf, and —(CH2)rNRfRf;
- Rf, at each occurrence, is independently selected from H, C1-5 alkyl, C3-6 cycloalkyl, and phenyl, or Rf and Rf together with the nitrogen atom to which they are both attached form a heterocyclic ring optionally substituted with C1-4alkyl;
- p, at each occurrence, is independently selected from zero, 1, and 2;
- and
- r, at each occurrence, is independently selected from zero, 1, 2, 3, and 4.
22 more elements
Dependencies are inferred from the claim text.